Millennium Management »

Tscan Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $578k 99k 5.83
2022-12-31 $31k 19k 1.61
2021-09-30 $252k 30k 8.33

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
Deer Management
Alphabet
Simplify Asset Management
Standard Life Aberdeen
Stifel Financial
Marshall Wace
Millennium Management
NewEdge Wealth
Jane Street

View all funds holding Tscan Therapeutics